BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$725M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$694M |
| 3 |
Microsoft
MSFT
|
+$320M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$216M |
| 5 |
Amazon
AMZN
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$153M |
| 2 |
Bank of America
BAC
|
+$130M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$62.1M |
| 4 |
STJ
St Jude Medical
STJ
|
+$55.6M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$50.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.95% |
| 2 | Financials | 11.02% |
| 3 | Healthcare | 9.12% |
| 4 | Communication Services | 8.65% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Nicolet Bankshares
NIC
$3.74B
| $2.75K | ﹤0.01% |
58
-368
| -86% | -$17.7K |
|
|
FMI
3402
DELISTED
Foundation Medicine, Inc.
FMI
| $2.74K | ﹤0.01% |
85
-669
| -89% | -$16.7K |
|
|
MOBL
3403
DELISTED
MobileIron, Inc.
MOBL
| $2.73K | ﹤0.01% |
628
-384
| -38% | -$1.7K |
|
|
PCBK
3404
DELISTED
Pacific Continental Corp
PCBK
| $2.72K | ﹤0.01% |
111
-618
| -85% | -$15.3K |
|
|
ESPR
3405
DELISTED
Esperion Therapeutics
ESPR
| $2.72K | ﹤0.01% |
77
-166
| -68% | -$3.8K |
|
3406
Atara Biotherapeutics
ATRA
$81.5M
| $2.71K | ﹤0.01% |
5
-47
| -90% | -$19.5K |
|
|
CSS
3407
DELISTED
CSS Industries, Inc.
CSS
| $2.7K | ﹤0.01% |
104
-387
| -79% | -$9.8K |
|
3408
Constellium
CSTM
$4.04B
| $2.67K | ﹤0.01% |
410
-451
| -52% | -$3.22K |
|
3409
PUT
Terex
TEX
$7.78B
| $2.66K | ﹤0.01% |
+70
| New | +$2.2K |
|
|
CTT
3410
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $2.65K | ﹤0.01% |
230
-442
| -66% | -$4.79K |
|
|
IMGN
3411
DELISTED
Immunogen Inc
IMGN
| $2.65K | ﹤0.01% |
684
-4,329
| -86% | -$12.6K |
|
3412
Graham Corp
GHM
$1.33B
| $2.65K | ﹤0.01% |
115
-96
| -45% | -$2.19K |
|
3413
Old Second Bancorp
OSBC
$1.31B
| $2.64K | ﹤0.01% |
235
-275
| -54% | -$2.96K |
|
|
RVNC
3414
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.64K | ﹤0.01% |
127
-1,019
| -89% | -$20.9K |
|
3415
Pacific Biosciences
PACB
$339M
| $2.64K | ﹤0.01% |
510
-885
| -63% | -$4.33K |
|
|
BMTC
3416
DELISTED
Bryn Mawr Bank Corp
BMTC
| $2.61K | ﹤0.01% |
66
-1,008
| -94% | -$40.8K |
|
|
UCFC
3417
DELISTED
United Community Financial Corp
UCFC
| $2.6K | ﹤0.01% |
312
-1,445
| -82% | -$12.4K |
|
3418
CALL
Hartford Financial Services
HIG
$37.8B
| $2.6K | ﹤0.01% |
+25
| New | +$1.21K |
|
3419
Winmark
WINA
$1.27B
| $2.6K | ﹤0.01% |
23
-108
| -82% | -$12.4K |
|
3420
Miller Industries
MLR
$636M
| $2.58K | ﹤0.01% |
98
-717
| -88% | -$18.3K |
|
3421
First Mid Bancshares
FMBH
$1.38B
| $2.57K | ﹤0.01% |
76
-77
| -50% | -$2.51K |
|
3422
Flexsteel Industries
FLXS
$303M
| $2.57K | ﹤0.01% |
51
-492
| -91% | -$25.6K |
|
3423
Lifecore Biomedical
LFCR
$184M
| $2.57K | ﹤0.01% |
214
-258
| -55% | -$3.27K |
|
3424
Pathward Financial
CASH
$1.8B
| $2.57K | ﹤0.01% |
87
-1,851
| -96% | -$57.2K |
|
|
CEMP
3425
DELISTED
Cempra, Inc.
CEMP
| $2.56K | ﹤0.01% |
684
-2,543
| -79% | -$8.82K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2017 Portfolio in Review
As of Q1 2017, BNP Paribas Financial Markets held 4,403 positions worth $37.9B, up 77% from $21.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $14.9B of net new capital in Q1 2017, opening 244 new positions and adding to 1,412 existing holdings. Its largest new stake was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $153M trimmed.
- BNP Paribas Financial Markets's largest Q1 2017 buy was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
- BNP Paribas Financial Markets added most to Apple in Q1 2017, an estimated $725M increase.
- BNP Paribas Financial Markets's biggest Q1 2017 reduction was iShares US Real Estate ETF, cutting an estimated $153M.
- BNP Paribas Financial Markets fully exited St Jude Medical in Q1 2017, selling an estimated $55.6M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $37.9B portfolio in Q1 2017.
- BNP Paribas Financial Markets opened 244 new positions and closed 335 in Q1 2017.
- BNP Paribas Financial Markets's portfolio value rose 77% quarter-over-quarter to $37.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2017, filed 3 May 2017.